318 lines (317 with data), 10.8 kB
T1 Age 2 13 53-year-old
T2 Sex 14 19 woman
T3 Clinical_event 20 29 presented
E1 Clinical_event:T3
T4 Nonbiological_location 37 48 institution
R1 MODIFY Arg1:T4 Arg2:E1
T5 Sign_symptom 76 86 distention
E2 Sign_symptom:T5
T6 Biological_structure 66 75 abdominal
T7 Detailed_description 54 65 progressive
R2 MODIFY Arg1:T6 Arg2:E2
R3 MODIFY Arg1:T7 Arg2:E2
T8 Sign_symptom 109 117 bleeding
E3 Sign_symptom:T8
T9 Biological_structure 101 108 vaginal
T10 Detailed_description 91 100 irregular
R4 MODIFY Arg1:T9 Arg2:E3
R5 MODIFY Arg1:T10 Arg2:E3
T11 Duration 121 134 several weeks
E4 Duration:T11
T12 Sign_symptom 214 218 mass
E5 Sign_symptom:T12
T13 Diagnostic_procedure 157 159 CT
E6 Diagnostic_procedure:T13
T14 Detailed_description 148 156 contrast
T15 Biological_structure 160 167 abdomen
T16 Biological_structure 172 178 pelvis
R6 MODIFY Arg1:T14 Arg2:E6
R7 MODIFY Arg1:T15 Arg2:E6
R8 MODIFY Arg1:T16 Arg2:E6
T17 Detailed_description 191 202 ill-defined
T18 Detailed_description 204 213 irregular
R9 MODIFY Arg1:T18 Arg2:E5
R10 MODIFY Arg1:T17 Arg2:E5
T19 Biological_structure 226 239 lower uterine
T20 Biological_structure 240 255 cervical region
R11 MODIFY Arg1:T19 Arg2:E5
R12 MODIFY Arg1:T20 Arg2:E5
T21 Sign_symptom 311 317 masses
E7 Sign_symptom:T21
T22 Biological_structure 303 310 omental
T23 Biological_structure 288 298 peritoneal
T24 Detailed_description 279 287 multiple
R13 MODIFY Arg1:T22 Arg2:E7
R14 MODIFY Arg1:T23 Arg2:E7
R15 MODIFY Arg1:T24 Arg2:E7
T25 Sign_symptom 319 327 enlarged
E8 Sign_symptom:T25
T26 Biological_structure 350 361 lymph nodes
R16 MODIFY Arg1:T26 Arg2:E8
T27 Biological_structure 328 334 pelvic
T28 Biological_structure 339 349 paraaortic
R17 MODIFY Arg1:T28 Arg2:T26
R18 MODIFY Arg1:T27 Arg2:T26
T29 Sign_symptom 380 387 ascites
E9 Sign_symptom:T29
T30 Detailed_description 367 379 large-volume
R19 MODIFY Arg1:T30 Arg2:E9
T31 Diagnostic_procedure 401 404 CBC
E10 Diagnostic_procedure:T31
T32 Diagnostic_procedure 425 435 hemoglobin
E11 Diagnostic_procedure:T32
T33 Lab_value 439 447 9.2 g/dL
R20 MODIFY Arg1:T33 Arg2:E11
T34 Sign_symptom 449 461 leukocytosis
E12 Sign_symptom:T34
T35 Lab_value 465 486 36 790 per microliter
R21 MODIFY Arg1:T35 Arg2:E12
T36 Sign_symptom 492 506 thrombocytosis
E13 Sign_symptom:T36
T37 Lab_value 510 532 625 000 per microliter
R22 MODIFY Arg1:T37 Arg2:E13
R23 SUB_PROCEDURE Arg1:E11 Arg2:E10
T38 Diagnostic_procedure 540 547 calcium
E14 Diagnostic_procedure:T38
T39 Biological_structure 534 539 Serum
R24 MODIFY Arg1:T39 Arg2:E14
T40 Lab_value 552 560 elevated
R25 MODIFY Arg1:T40 Arg2:E14
T41 Lab_value 564 574 13.1 mg/dL
R26 MODIFY Arg1:T41 Arg2:E14
T42 Diagnostic_procedure 576 579 BUN
E15 Diagnostic_procedure:T42
T43 Diagnostic_procedure 584 594 creatinine
E16 Diagnostic_procedure:T43
T44 Lab_value 600 620 within normal limits
R27 MODIFY Arg1:T44 Arg2:E16
R28 MODIFY Arg1:T44 Arg2:E15
T45 Diagnostic_procedure 622 638 Hepatic function
E17 Diagnostic_procedure:T45
T46 Lab_value 643 663 within normal limits
R29 MODIFY Arg1:T46 Arg2:E17
T47 Diagnostic_procedure 667 678 pelvic exam
E18 Diagnostic_procedure:T47
T48 Sign_symptom 708 712 mass
E19 Sign_symptom:T48
T49 Detailed_description 690 699 fungating
T50 Biological_structure 700 707 vaginal
R30 MODIFY Arg1:T50 Arg2:E19
R31 MODIFY Arg1:T49 Arg2:E19
T51 Diagnostic_procedure 736 744 biopsies
E20 Diagnostic_procedure:T51
T52 Biological_structure 752 763 endometrium
R32 MODIFY Arg1:T52 Arg2:E20
T53 Coreference 780 784 mass
E21 Coreference:T53
R33 IDENTICAL Arg1:E21 Arg2:E19
T54 Biological_structure 772 779 vaginal
R34 MODIFY Arg1:T54 Arg2:E21
R35 MODIFY Arg1:E21 Arg2:E20
T55 Sign_symptom 814 819 tumor
E22 Sign_symptom:T55
T56 Severity 803 813 high-grade
R36 MODIFY Arg1:T56 Arg2:E22
T57 Detailed_description 825 856 predominantly oval-shaped cells
R37 MODIFY Arg1:T57 Arg2:E22
T58 Diagnostic_procedure 858 886 Immunohistochemical staining
E23 Diagnostic_procedure:T58
T59 Diagnostic_procedure 904 912 vimentin
E24 Diagnostic_procedure:T59
T60 Diagnostic_procedure 914 918 CD10
E25 Diagnostic_procedure:T60
T61 Diagnostic_procedure 924 933 cyclin D1
E26 Diagnostic_procedure:T61
T62 Lab_value 891 899 positive
R38 SUB_PROCEDURE Arg1:E24 Arg2:E23
R39 SUB_PROCEDURE Arg1:E25 Arg2:E23
R40 SUB_PROCEDURE Arg1:E26 Arg2:E23
R41 MODIFY Arg1:T62 Arg2:E24
R42 MODIFY Arg1:T62 Arg2:E25
R43 MODIFY Arg1:T62 Arg2:E26
T63 Disease_disorder 977 1004 endometrial stromal sarcoma
E27 Disease_disorder:T63
T64 Severity 966 976 high-grade
R44 MODIFY Arg1:T64 Arg2:E27
T65 Coreference 1021 1026 tumor
E28 Coreference:T65
R45 IDENTICAL Arg1:E28 Arg2:E27
T67 Diagnostic_procedure 1044 1046 ER
E30 Diagnostic_procedure:T67
#1 AnnotatorNotes E30 estrogen receptor
T66 Lab_value 1031 1039 negative
R46 MODIFY Arg1:T66 Arg2:E30
T68 Diagnostic_procedure 1077 1079 PR
E29 Diagnostic_procedure:T68
#2 AnnotatorNotes E29 progesterone receptor
T69 Lab_value 1064 1072 positive
R47 MODIFY Arg1:T69 Arg2:E29
T70 Detailed_description 1053 1063 rare cells
R48 MODIFY Arg1:T70 Arg2:E29
R49 MODIFY Arg1:E28 Arg2:E30
R50 MODIFY Arg1:E28 Arg2:E29
T71 Diagnostic_procedure 1090 1118 immunohistochemical staining
E31 Diagnostic_procedure:T71
T72 Diagnostic_procedure 1123 1135 cytokeratins
E32 Diagnostic_procedure:T72
T73 Lab_value 1140 1148 negative
R51 MODIFY Arg1:T73 Arg2:E32
T74 Sign_symptom 1152 1170 biphasic component
E33 Sign_symptom:T74
A1 POLARITY E33 UNCERTAIN
R52 SUB_PROCEDURE Arg1:E32 Arg2:E31
T75 Diagnostic_procedure 1284 1289 Ca125
E34 Diagnostic_procedure:T75
T76 Lab_value 1303 1311 elevated
T77 Lab_value 1315 1324 1624 U/mL
R53 MODIFY Arg1:T76 Arg2:E34
R54 MODIFY Arg1:T77 Arg2:E34
T78 Diagnostic_procedure 1344 1346 CT
E35 Diagnostic_procedure:T78
T79 Detailed_description 1335 1343 Contrast
R55 MODIFY Arg1:T79 Arg2:E35
T80 Biological_structure 1347 1352 chest
R56 MODIFY Arg1:T80 Arg2:E35
T81 Disease_disorder 1376 1392 pleural effusion
E36 Disease_disorder:T81
T82 Detailed_description 1364 1375 right-sided
R57 MODIFY Arg1:T82 Arg2:E36
T83 Sign_symptom 1411 1418 nodules
E37 Sign_symptom:T83
A2 POLARITY E37 NEG
T84 Disease_disorder 1422 1437 lymphadenopathy
E38 Disease_disorder:T84
A3 POLARITY E38 NEG
T85 Detailed_description 1400 1410 suspicious
R58 MODIFY Arg1:T85 Arg2:E37
T86 Disease_disorder 1470 1486 operable disease
E39 Disease_disorder:T86
T87 Therapeutic_procedure 1509 1526 debulking surgery
E40 Therapeutic_procedure:T87
T88 Diagnostic_procedure 1550 1568 laboratory studies
E41 Diagnostic_procedure:T88
T89 Diagnostic_procedure 1591 1598 calcium
E42 Diagnostic_procedure:T89
T90 Biological_structure 1585 1590 serum
R59 MODIFY Arg1:T90 Arg2:E42
R60 SUB_PROCEDURE Arg1:E42 Arg2:E41
T91 Lab_value 1611 1620 increased
T92 Lab_value 1624 1634 19.2 mg/dL
R61 MODIFY Arg1:T91 Arg2:E42
R62 MODIFY Arg1:T92 Arg2:E42
T93 Disease_disorder 1684 1690 injury
E43 Disease_disorder:T93
T94 Biological_structure 1677 1683 kidney
R63 MODIFY Arg1:T94 Arg2:E43
T95 Detailed_description 1671 1676 acute
R64 MODIFY Arg1:T95 Arg2:E43
T96 Diagnostic_procedure 1701 1704 BUN
E44 Diagnostic_procedure:T96
T97 Lab_value 1705 1711 rising
T98 Lab_value 1715 1723 37 mg/dL
R65 MODIFY Arg1:T97 Arg2:E44
R66 MODIFY Arg1:T98 Arg2:E44
T99 Diagnostic_procedure 1728 1738 creatinine
E45 Diagnostic_procedure:T99
T100 Lab_value 1742 1752 1.81 mg/dL
R67 MODIFY Arg1:T100 Arg2:E45
T101 Diagnostic_procedure 1757 1770 physical exam
E46 Diagnostic_procedure:T101
T102 Sign_symptom 1792 1801 lethargic
E47 Sign_symptom:T102
T104 Therapeutic_procedure 1834 1841 surgery
E49 Therapeutic_procedure:T104
A4 POLARITY E49 NEG
A5 POLARITY E40 UNCERTAIN
T105 Clinical_event 1846 1855 cancelled
E50 Clinical_event:T105
T106 Disease_disorder 1877 1896 medical instability
E51 Disease_disorder:T106
T107 Diagnostic_procedure 1934 1939 PTHrP
E52 Diagnostic_procedure:T107
T108 Lab_value 1925 1933 elevated
T109 Lab_value 1943 1952 301 pg/mL
R68 MODIFY Arg1:T109 Arg2:E52
R69 MODIFY Arg1:T108 Arg2:E52
T110 Lab_value 1967 1976 depressed
T111 Diagnostic_procedure 1977 1980 PTH
E53 Diagnostic_procedure:T111
T112 Lab_value 1990 1997 3 pg/mL
R70 MODIFY Arg1:T112 Arg2:E53
R71 MODIFY Arg1:T110 Arg2:E53
T113 Lab_value 2016 2025 depressed
T114 Diagnostic_procedure 2026 2041 25-OH vitamin D
E54 Diagnostic_procedure:T114
T115 Lab_value 2051 2059 16 ng/mL
R72 MODIFY Arg1:T115 Arg2:E54
R73 MODIFY Arg1:T113 Arg2:E54
T116 Disease_disorder 2089 2124 humoral hypercalcemia of malignancy
E55 Disease_disorder:T116
T117 Medication 2155 2166 pamidronate
E56 Medication:T117
T118 Medication 2168 2178 calcitonin
E57 Medication:T118
T119 Medication 2196 2202 fluids
E58 Medication:T119
T120 Administration 2184 2195 intravenous
R74 MODIFY Arg1:T120 Arg2:E58
T121 Therapeutic_procedure 2238 2250 hemodialysis
E59 Therapeutic_procedure:T121
T122 Detailed_description 2228 2237 temporary
R75 MODIFY Arg1:T122 Arg2:E59
T123 Medication 2255 2264 denosumab
E60 Medication:T123
T124 Sign_symptom 2280 2293 hypercalcemia
E61 Sign_symptom:T124
T125 Detailed_description 2269 2279 refractory
R76 MODIFY Arg1:T125 Arg2:E61
T126 Coreference 2335 2360 electrolyte abnormalities
E62 Coreference:T126
R77 IDENTICAL Arg1:E62 Arg2:E61
A6 TREND E62 DEC
T127 Medication 2427 2439 chemotherapy
E63 Medication:T127
A7 POLARITY E63 UNCERTAIN
T128 Therapeutic_procedure 2452 2459 surgery
E64 Therapeutic_procedure:T128
A8 POLARITY E64 UNCERTAIN
T129 Medication 2525 2536 carboplatin
E65 Medication:T129
T130 Medication 2541 2551 paclitaxel
E66 Medication:T130
T131 Dosage 2576 2584 3 cycles
R78 MODIFY Arg1:T131 Arg2:E66
R79 MODIFY Arg1:T131 Arg2:E65
T132 Therapeutic_procedure 2610 2619 radiation
E67 Therapeutic_procedure:T132
T133 Biological_structure 2627 2633 uterus
R80 MODIFY Arg1:T133 Arg2:E67
T134 Sign_symptom 2645 2653 bleeding
E68 Sign_symptom:T134
T135 Outcome 2744 2748 died
E69 Outcome:T135
T136 Disease_disorder 2754 2781 complications of malignancy
E70 Disease_disorder:T136
R81 CAUSE Arg1:E70 Arg2:E69
R82 AFTER Arg1:E1 Arg2:E2
* OVERLAP E2 E3 E4
R83 BEFORE Arg1:E4 Arg2:E6
* OVERLAP E6 E5 E7 E8 E9 E10 E12 E13 E14 E15 E16 E17 E18 E19 E20 E22 E23 E27 E28 E30 E29 E31 E33 E34 E35 E36 E37 E38 E39 E40
R84 BEFORE Arg1:E40 Arg2:E41
* OVERLAP E41 E43 E44 E45 E46 E47 E48
T103 Sign_symptom 1808 1811 dry
E48 Sign_symptom:T103
T137 Biological_structure 1812 1828 mucous membranes
R85 MODIFY Arg1:T137 Arg2:E48
R86 BEFORE Arg1:E48 Arg2:E49
* OVERLAP E49 E50 E51 E52 E53 E54 E55
R87 MODIFY Arg1:E49 Arg2:E50
R88 BEFORE Arg1:E55 Arg2:E56
* OVERLAP E56 E57 E58
R89 BEFORE Arg1:E58 Arg2:E59
* OVERLAP E59 E60 E61
R90 BEFORE Arg1:E61 Arg2:E62
* OVERLAP E62 E63 E64
R91 BEFORE Arg1:E64 Arg2:E65
* OVERLAP E65 E66 E67 E68
R92 BEFORE Arg1:E68 Arg2:E69